18F-fluorodeoxyglucose positron emission/computed tomography in the diagnosis and follow-up of tuberculosis

18F-fluorodeoxyglucose positron emission/computed tomography in the diagnosis and follow-up of tuberculosis

Bibliographic Details
Main Authors:	Dhaval K Thakkar, Vilas M Kulkarni, Tanmayi V Kulkarni, Amarjit Singh, Venus Pagare
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-01-01
Series:	Medical Journal of Dr. D.Y. Patil University
Online Access:	http://www.mjdrdypu.org/article.asp?issn=0975-2870;year=2016;volume=9;issue=3;spage=420;epage=421;aulast=Thakkar

Similar Items

Neurolymphomatosis detected by 18F‐fluorodeoxyglucose‐positron emission tomography
by: Yoshikazu Hori, et al.
Published: (2020-07-01)

The 18F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer
by: Mihailović Jasna, et al.
Published: (2017-01-01)

Candida pyelonephritis on 18F-fluorodeoxyglucose positron emission tomography/computed tomography
by: Junwei Zhang, et al.
Published: (2016-10-01)

Addison’s disease due to bilateral adrenal tuberculosis on 18F-fluorodeoxyglucose positron emission tomography computed tomography
by: Sung Ae Koh
Published: (2018-09-01)

18F-fluorodeoxyglucose and 18F-flumazenil positron emission tomography in patients with refractory epilepsy
by: Hodolic Marina, et al.
Published: (2016-09-01)

18F-Fluorodeoxyglucose positron emission tomography may not visualize radiation pneumonitis
by: Meiying Guo, et al.
Published: (2019-12-01)

18F fluorodeoxyglucose positron-emission tomography–computed tomography in the diagnosis of brachial plexopathy in carcinoma breast
by: Suma Tammineni Medara, et al.
Published: (2022-01-01)

The role of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in the differential diagnosis of pericardial disease
by: Cheol Won Hyeon, et al.
Published: (2020-12-01)

Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose
by: Jing Zhu, et al.
Published: (2022-10-01)

18F-fluorodeoxyglucose positron emission tomography / computed tomography in primary Ewing sarcoma of the lung
by: Zivgarević Ljiljana, et al.
Published: (2022-01-01)

The Role of Preoperative 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Retroperitoneal Sarcoma
by: Sung Jun Jo, et al.
Published: (2022-05-01)

18F-fluorodeoxyglucose positron emission tomography/computed tomography of bilateral primary ureter lymphoma
by: Liang Yin, et al.
Published: (2021-05-01)

Towards more accurate 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) imaging in active and latent tuberculosis
by: Dimitris Priftakis, et al.
Published: (2020-03-01)

Diagnostic Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Gastric Mesenchymal Tumors
by: Masaya Iwamuro, et al.
Published: (2020-05-01)

18F-Fluorodeoxyglucose Positron Emission Tomography Is Useful in the Evaluation of Prognosis in Retroperitoneal Sarcoma
by: Toru Wakamatsu, et al.
Published: (2021-09-01)

18F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging evaluation of chorea
by: Nobuyuki Ishii, et al.
Published: (2018-09-01)

Tuberculous encephalitis with aphemia detected only by 18F-fluorodeoxyglucose-positron emission tomography
by: Boby Varkey Maramattom, et al.
Published: (2019-01-01)

In vitro imaging of bacteria using 18F-fluorodeoxyglucose micro positron emission tomography
by: Marjolein Heuker, et al.
Published: (2017-07-01)

Multiple lytic lesions on F-18 fluorodeoxyglucose positron emission tomography/computed tomography not always metastatic?
by: Averilicia Passah, et al.
Published: (2018-01-01)

Diagnostic utility of positron emission tomography-computed tomography and indications for 18F-Fluorodeoxyglucose and amyloid-tracers
by: Maria Lucia Calcagni, et al.
Published: (2018-11-01)

Quantitative 18F-fluorodeoxyglucose positron emission tomography/computed tomography to assess pulmonary inflammation in COPD
by: Laurence Vass, et al.
Published: (2021-08-01)

Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating lung cancer recurrence
by: Nobuhiro Asai, et al.
Published: (2013-04-01)

Clinical utility of 18fluorodeoxyglucose positron emission tomography-computed tomography in rheumatology
by: Sirisha Kommireddy, et al.
Published: (2021-01-01)

The utility of [18]F-fluorocholine positron emission computed tomography and [18]F-fluorodeoxyglucose positron emission tomography–computed tomography in evaluating breast cancer phenotypes: a pilot study
by: Zakaria, Mohd Hazeman, et al.
Published: (2024)

Comparison of <sup>18</sup>F-fluorothymidine Positron Emission Tomography/Computed Tomography and <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
by: Mio Mori, et al.
Published: (2022-10-01)

18F-fluorodeoxyglucose–positron emission tomography/computed tomography for the diagnosis of polymyalgia-like illnesses: a retrospective study
by: Hideyuki Horikoshi, et al.
Published: (2020-04-01)

Value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography ın the diagnosis of carcinoma of unknown primary origin
by: Claudia González Espinosa, et al.
Published: (2019-11-01)

The emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with sarcoidosis
by: Silvia Taralli, et al.
Published: (2012-01-01)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
by: Gillies, R, et al.
Published: (2010)

Assessment of Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Carcinoma of Unknown Primary
by: S. A. Yaremenko, et al.
Published: (2021-09-01)

[18F]fluorodeoxyglucose positron emission tomography/computed tomography characteristics of primary mediastinal germ cell tumors
by: Koeun Lee, et al.
Published: (2023-10-01)

A case report of calcific aterosclerosis demonstrated on 18-F-fluorodeoxyglucose positron emission tomography/computed tomography
by: Antonella Laria, et al.
Published: (2021-10-01)

Intracranial Leptomeningeal Carcinomatosis: A Diagnostic Study with 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
by: Susanna Nuvoli, et al.
Published: (2018-02-01)

Primary spindle cell sarcoma of the prostate and 18 F-fluorodeoxyglucose-positron-emission tomography/computed tomography findings
by: Hakan Öztürk
Published: (2015-01-01)

Recurrent Proliferating Trichilemmal Tumor with Malignant Change on the F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
by: Eun Ha Moon, et al.
Published: (2016-06-01)

18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in the Management of Metastatic Colorectal Cancer; Are we there yet?
by: Khalid Al-Naamani, et al.
Published: (2015-05-01)

18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in the Management of Metastatic Colorectal Cancer : Are we there yet?
by: Khalid Al-Naamani, et al.
Published: (2015-05-01)

18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IN CANCER PATIENTS: A WHOLE-BODY EXAMINATION PROCEDURE
by: O. V. Mukhortova, et al.
Published: (2014-09-01)

Intense Pituitary 18F-Fluorodeoxyglucose Positron Emission Tomography Uptake in a Patient with Diabetes Insipidus
by: Çiğdem Soydal, et al.
Published: (2019-07-01)

Brain laterality evaluated by F-18 fluorodeoxyglucose positron emission computed tomography in autism spectrum disorders
by: Keattichai Keeratitanont, et al.
Published: (2022-08-01)